Correlation between serum CRP at baseline and serum IL-6 at baseline or after tocilizumab administration. ■ and ● show patients with RA and patients with Castleman disease, respectively. The x-axis shows (A) serum IL-6 at baseline (r² = .19) and (B) serum IL-6 after tocilizumab infusion (r² = .67).